Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions.

@article{Geldmacher2004DonepezilF,
  title={Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions.},
  author={David S. Geldmacher},
  journal={Expert review of neurotherapeutics},
  year={2004},
  volume={4 1},
  pages={
          5-16
        }
}
Alzheimer's disease is common, incurable and disabling. It is expected to grow dramatically in prevalence over the next 50 years. At current, the standard of care for patients with mild and moderately severe Alzheimer's disease includes the use of acetylcholinesterase inhibitors. Donepezil (Aricept) is a highly selective acetylcholinesterase inhibitors with a pharmacokinetic profile allowing once-daily dosing. There is an extensive knowledge base derived from published clinical trials of… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Similar Papers

Loading similar papers…